Flatiron Health is a market leader in oncology-specific real-world evidence and EHR-integrated clinical data, maintaining a strong position as a subsidiary of Roche.
Market Share: Flatiron is widely considered a top-tier provider of oncology-specific real-world data, though specific market share percentages are not publicly disclosed.
The oncology healthcare technology sector is highly competitive, characterized by the convergence of clinical data, genomic insights, and AI-driven analytics to accelerate drug development and improve patient care.
A global leader in clinical research and data analytics that competes with Flatiron in the real-world evidence (RWE) and life sciences data space.
Strengths
Weaknesses
Focuses on precision medicine by combining clinical data with molecular/genomic data, directly competing for oncology research partnerships.
Strengths
Weaknesses
Specializes in precision oncology data, helping health systems and life sciences companies use clinical and molecular data to improve patient outcomes.
Strengths
Weaknesses
An Alphabet company that utilizes data analytics and clinical research platforms to improve healthcare, overlapping with Flatiron's data-driven research initiatives.
Strengths
Weaknesses
Unparalleled depth of structured oncology data
Strong relationships with major cancer centers and academic institutions
Proven ability to support regulatory-grade real-world evidence studies
Rapid evolution of genomic-based precision medicine
Increasing data privacy regulations
Competition from large-scale tech companies entering the healthcare data space
Practice for Flatiron Health with an AI Agent
Uses this company profile to tailor behavioral, role, and culture questions